Chat with us, powered by LiveChat
BUY TICKETS

SAVE $1401 BY MAY. 7

 Speaker Profile

Director, UCLA

Biography
David S. Liebeskind, MD, FAHA, FAAN is Professor of Neurology at the University of California, Los Angeles (UCLA) where he serves as the Associate Neurology Director of the UCLA Stroke Center and the Neurology Director of the Stroke Imaging Program. He is Co-Director of the UCLA Cerebral Blood Flow Laboratory and Director of the UCLA Vascular Neurology Residency Program.He trained in chemical engineering at Columbia University and completed his MD at New York University School of Medicine. Postgraduate medical training included internship at Beth Israel Hospital, Boston and neurology residency at UCLA. After his residency, he completed a fellowship in stroke and cerebrovascular disease at UCLA and subsequently joined the faculty in the Departments of Neurology and Radiology at the University of Pennsylvania.He has maintained extensive clinical activity across a broad range of cerebrovascular disorders ranging from carotid disease to unusual causes of stroke. Clinical expertise includes cerebral venous thrombosis, arterial dissection, moyamoya syndrome and other causes of stroke in the young. His principal research interests include novel neuroimaging approaches to elucidate fundamental pathophysiologic correlates of cerebrovascular disease in humans with a particular focus on the collateral circulation. His work on collateral perfusion in acute ischemic stroke draws on advances in noninvasive, multimodal CT and MRI and detailed analyses of digital subtraction angiography. He directs an angiography and imaging core laboratory that has participated in central readings of MERCI, Multi MERCI, IMS-III, TREVO EU and TREVO 2. His research on collaterals in intracranial atherosclerosis complements his work on acute stroke, utilizing computational fluid dynamic modeling and estimates of fractionalflow to predict risk of ischemia and reperfusion hemorrhage.


 Session Abstract – PMWC 2027 Silicon Valley

Showcase Track S2 - March 4 11.30 A.M.-2.30 P.M.,Showcase Track S2 - March 5 1.00 P.M.-2.00 P.M.,Showcase Track S1 - March 6 2.45 P.M.-1.45 P.M.


Track Chair:
Ira Mellman, Medici Therapeutics

PMWC Award Ceremony
• Jedd D. Wolchok, Weill Cornell Medicine
• Suzanne Topalian, Johns Hopkins
• Levi Garraway, Roche

Keynote: Future Breakthroughs in Immuno-Oncology: New Targets, Modalities & Combinations
• Levi Garraway, Roche

Checkpoint 2.0 in Practice: PD-1+VEGF Wins, Resistance Salvage & Biomarker Gates
• Chair: Anne Kasmar, Parexel
• Jedd D. Wolchok, Weill Cornell Medicine
• Roy S. Herbst, Yale
• Nathan Fowler, BostonGene

Immunotherapy with Personalized Cancer Vaccines: Who, When, How Fast?
• Chair: Suzanne Topalian, Johns Hopkins
• Tal Zaks, Orbimed
• Lelia Delamarre, Genentech

The Next Era: Neutralizing On-Target, Off-Tumor Effects by Turning Cancer Against Itself
• Cyriac Roeding, Earli

Fireside Chat: Immune Tolerance to Cure, A Conversation With...
• Lee Hood, Institute for Systems Biology
• Mary E. Brunkow, Institute for Systems Biology

ADCs in the Checkpoint Era: Who Benefits, What to Combine, What to Avoid
• Chair: Shreya Badhrinarayanan, Pfizer
• Gerold Meinhardt, Daiichi Sankyo
• Vadim Koshkin, UCSF

Strategic IP Management in Cell and Gene Therapy: Navigating Legal and Practical Challenges
• Janet Xiao, Morrison & Foerster LLP

Targeting the Tumor Microenvironment (TME) in Practice: Biomarkers & Combos
• Chair: Ira Mellman, Medici Therapeutics
• Dmitry Gabrilovich, AstraZeneca
• Jennifer Mataraza, Novartis
• Nathan Fowler, BostonGene
• Christine Moussion, Genentech

Future Breakthroughs in TME Reprogramming: New Modalities, Smarter Delivery & Overcoming Resistance
• David Kirn, ReIGNITE
Radiopharmaceutical Therapy: New Targets, Isotopes, and Challenges
• Chair: William Oh, Yale
• Munir Ghesani, United Theranostics
• Sandy Srinivas, Stanford
• Anna Karmann, AdvanCell

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by MAY. 7TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Request Atul Butte Company Competition Submission Form

Fields marked with an * are required

Contact Us:

Fields marked with an * are required 

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required